Effects of MRI Protocol Parameters, Preload Injection Dose, Fractionation Strategies, and Leakage Correction Algorithms on the Fidelity of Dynamic-Susceptibility Contrast MRI Estimates of Relative Cerebral Blood Volume in Gliomas

References

1. 1.↵
   2. Meier P,
   3. Zierler KL

   . On the theory of the indicator-dilution method for measurement of blood flow and volume. J Appl Physiol 1954;6:731–44 pmid:13174454

   FREE Full Text
2. 2.↵
   2. Essig M,
   3. Nguyen TB,
   4. Shiroishi MS, et al

   . Perfusion MRI: the five most frequently asked clinical questions. AJR Am J Roentgenol 2013;201:W495–510 doi:10.2214/AJR.12.9544 pmid:23971482

   CrossRefPubMed
3. 3.↵
   2. Petrella JR,
   3. Provenzale JM

   . MR perfusion imaging of the brain: techniques and applications. AJR Am J Roentgenol 2000;175:207–19 doi:10.2214/ajr.175.1.1750207 pmid:10882275

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Paulson ES,
   3. Schmainda KM

   . Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring relative cerebral blood volume in brain tumors. Radiology 2008;249:601–13 doi:10.1148/radiol.2492071659 pmid:18780827

   CrossRefPubMedWeb of Science
5. 5.↵
   2. Cha S,
   3. Knopp EA,
   4. Johnson G, et al

   . Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging. Radiology 2002;223:11–29 doi:10.1148/radiol.2231010594 pmid:11930044

   CrossRefPubMedWeb of Science
6. 6.↵
   2. Vonken EJ,
   3. van Osch MJ,
   4. Bakker CJ, et al

   . Measurement of cerebral perfusion with dual-echo multi-slice quantitative dynamic susceptibility contrast MRI. J Magn Reson Imaging 1999;10:109–17 pmid:10441012

   CrossRefPubMed
7. 7.↵
   2. Schmiedeskamp H,
   3. Straka M,
   4. Newbould RD, et al

   . Combined spin- and gradient-echo perfusion-weighted imaging. Magn Reson Med 2012;68:30–40 doi:10.1002/mrm.23195 pmid:22114040

   CrossRefPubMed
8. 8.↵
   2. Skinner JT,
   3. Robison RK,
   4. Elder CP, et al

   . Evaluation of a multiple spin- and gradient-echo (SAGE) EPI acquisition with SENSE acceleration: applications for perfusion imaging in and outside the brain. Magn Reson Imaging 2014;32:1171–80 doi:10.1016/j.mri.2014.08.032 pmid:25179133

   CrossRefPubMed
9. 9.↵
   2. Boxerman JL,
   3. Prah DE,
   4. Paulson ES, et al

   . The role of preload and leakage correction in gadolinium-based cerebral blood volume estimation determined by comparison with MION as a criterion standard. AJNR Am J Neuroradiol 2012;33:1081–87 doi:10.3174/ajnr.A2934 pmid:22322605

   Abstract/FREE Full Text
10. 10.↵
    2. Boxerman JL,
    3. Schmainda KM,
    4. Weisskoff RM

    . Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not. AJNR Am J Neuroradiol 2006;27:859–67 pmid:16611779

    Abstract/FREE Full Text
11. 11.↵
    2. Leu K,
    3. Boxerman JB,
    4. Cloughesy TF, et al

    . Improved leakage correction for single-echo dynamic susceptibility contrast (DSC) perfusion MRI estimates of relative cerebral blood volume (rCBV) in high-grade gliomas by accounting for bidirectional contrast agent exchange. AJNR Am J Neuroradiol 2016;37:1440–46

    Abstract/FREE Full Text
12. 12.↵
    2. Bjornerud A,
    3. Sorensen AG,
    4. Mouridsen K, et al

    . T1- and T2*-dominant extravasation correction in DSC-MRI, Part I, theoretical considerations and implications for assessment of tumor hemodynamic properties. J Cereb Blood Flow Metab 2011;31:2041–53 doi:10.1038/jcbfm.2011.52 pmid:21505483

    Abstract/FREE Full Text
13. 13.↵
    2. Leu K,
    3. Boxerman JL,
    4. Lai A, et al

    . Bidirectional contrast agent leakage correction of dynamic susceptibility contrast (DSC)-MRI improves cerebral blood volume estimation and survival prediction in recurrent glioblastoma treated with bevacizumab. J Magn Reson Imaging 2016;44:1229–37 doi:10.1002/jmri.25227 pmid:26971534

    CrossRefPubMed
14. 14.↵
    2. Ostergaard L,
    3. Weisskoff RM,
    4. Chesler DA, et al

    . High resolution measurement of cerebral blood flow using intravascular tracer bolus passages, Part I: mathematical approach and statistical analysis. Magn Reson Med 1996;36:715–25 doi:10.1002/mrm.1910360510 pmid:8916022

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Quarles CC,
    3. Gochberg DF,
    4. Gore JC, et al

    . A theoretical framework to model DSC-MRI data acquired in the presence of contrast agent extravasation. Phys Med Biol 2009;54:5749–66 doi:10.1088/0031-9155/54/19/006 pmid:19729712

    CrossRefPubMed
16. 16.↵
    2. Simpson NE,
    3. He Z,
    4. Evelhoch JL

    . Deuterium NMR tissue perfusion measurements using the tracer uptake approach, I: optimization of methods. Magn Reson Med 1999;42:42–52 pmid:10398949

    PubMed
17. 17.↵
    2. Schmiedeskamp H,
    3. Andre JB,
    4. Straka M, et al

    . Simultaneous perfusion and permeability measurements using combined spin- and gradient-echo MRI. J Cereb Blood Flow Metab 2013;33:732–43 doi:10.1038/jcbfm.2013.10 pmid:23462570

    Abstract/FREE Full Text
18. 18.↵
    2. Pintaske J,
    3. Martirosian P,
    4. Graf H, et al

    . Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 Tesla. Invest Radiol 2006;41:213–21 doi:10.1097/01.rli.0000197668.44926.f7 pmid:16481903

    CrossRefPubMed
19. 19.↵
    2. Kjolby BF,
    3. Østergaard L,
    4. Kiselev VG

    . Theoretical model of intravascular paramagnetic tracers effect on tissue relaxation. Magn Reson Med 2006;56:187–97 doi:10.1002/mrm.20920 pmid:16724299

    CrossRefPubMed
20. 20.↵
    2. Wansapura JP,
    3. Holland SK,
    4. Dunn RS, et al

    . NMR relaxation times in the human brain at 3.0 Tesla. J Magn Reson Imaging 1999;9:531–38 pmid:10232510

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Zhang N,
    3. Zhang L,
    4. Qiu B, et al

    . Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas. J Magn Reson Imaging 2012;36:355–63 doi:10.1002/jmri.23675 pmid:22581762

    CrossRefPubMed
22. 22.↵
    2. Wu O,
    3. Østergaard L,
    4. Koroshetz WJ, et al

    . Effects of tracer arrival time on flow estimates in MR perfusion-weighted imaging. Magn Reson Med 2003;50:856–64 doi:10.1002/mrm.10610 pmid:14523973

    CrossRefPubMed
23. 23.↵
    2. van Osch MJ,
    3. Vonken EJ,
    4. Viergever MA, et al

    . Measuring the arterial input function with gradient echo sequences. Magn Reson Med 2003;49:1067–76 doi:10.1002/mrm.10461 pmid:12768585

    CrossRefPubMed
24. 24.↵
    2. Vonken EP,
    3. van Osch MJ,
    4. Bakker CJ, et al

    . Simultaneous quantitative cerebral perfusion and Gd-DTPA extravasation measurement with dual-echo dynamic susceptibility contrast MRI. Magn Reson Med 2000;43:820–27 pmid:10861876

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Welker K,
    3. Boxerman J,
    4. Kalnin A, et al

    ; American Society of Functional Neuroradiology MR Perfusion Standards and Practice Subcommittee of the ASFNR Clinical Practice Committee. ASFNR recommendations for clinical performance of MR dynamic susceptibility contrast perfusion imaging of the brain. AJNR Am J Neuroradiol 2015;36:E41–51 doi:10.3174/ajnr.A4341 pmid:25907520

    Abstract/FREE Full Text
26. 26.↵
    2. Liu HL,
    3. Wu YY,
    4. Yang WS, et al

    . Is Weisskoff model valid for the correction of contrast agent extravasation with combined T1 and T2* effects in dynamic susceptibility contrast MRI? Med Phys 2011;38:802–09 doi:10.1118/1.3534197 pmid:21452717

    CrossRefPubMed
27. 27.↵
    2. Hu LS,
    3. Baxter LC,
    4. Pinnaduwage DS, et al

    . Optimized preload leakage-correction methods to improve the diagnostic accuracy of dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging in posttreatment gliomas. AJNR Am J Neuroradiol 2010;31:40–48 doi:10.3174/ajnr.A1787 pmid:19749223

    Abstract/FREE Full Text
28. 28.↵
    2. Kassner A,
    3. Annesley DJ,
    4. Zhu XP, et al

    . Abnormalities of the contrast re-circulation phase in cerebral tumors demonstrated using dynamic susceptibility contrast-enhanced imaging: a possible marker of vascular tortuosity. J Magn Reson Imaging 2000;11:103–13 pmid:10713941

    CrossRefPubMed
29. 29.↵
    2. Pathak AP,
    3. Ward BD,
    4. Schmainda KM

    . A novel technique for modeling susceptibility-based contrast mechanisms for arbitrary microvascular geometries: the finite perturber method. Neuroimage 2008;40:1130–43 doi:10.1016/j.neuroimage.2008.01.022 pmid:18308587

    CrossRefPubMedWeb of Science
30. 30.↵
    2. Semmineh NB,
    3. Xu J,
    4. Boxerman JL, et al

    . An efficient computational approach to characterize DSC-MRI signals arising from three-dimensional heterogeneous tissue structures. PLoS One 2014;9:e84764 doi:10.1371/journal.pone.0084764 pmid:24416281

    CrossRefPubMed